Gamida Cell's average Accounts Receivable for the
three
months ended in Dec. 2023 was $1.14 Mil. Gamida Cell's Revenue for the
three
months ended in Dec. 2023 was $1.11 Mil.
Hence, Gamida Cell's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 93.88.
The historical rank and industry rank for Gamida Cell's Days Sales Outstanding or its related term are showing as below:
GMDAQ'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 233.85 Med: 329.4 Max: 329.4
Current: 233.85
During the past 8 years, Gamida Cell's highest Days Sales Outstanding was 329.40. The lowest was 233.85. And the median was 329.40.
GMDAQ's Days Sales Outstanding is ranked worse than 84.7% of 889
companies
in the Biotechnology industry
Industry Median: 71.83
vs GMDAQ: 233.85
Gamida Cell's Days Sales Outstanding
increased
from Dec. 2022 (0.00) to Dec. 2023 (93.88).
Gamida Cell Days Sales Outstanding Historical Data
The historical data trend for Gamida Cell's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gamida Cell's Days Sales Outstanding
For the Biotechnology subindustry, Gamida Cell's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gamida Cell's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gamida Cell's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Gamida Cell's Days Sales Outstanding falls into.
Gamida Cell Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gamida Cell (OTCPK:GMDAQ) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Gamida Cell Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Gamida Cell's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Gamida Cell Ltd is a clinical-stage biopharmaceutical company that is pioneering a diverse immunotherapy pipeline of potentially curative cell therapy candidates for patients with solid tumors and blood cancers and other serious blood diseases. The company applies a proprietary expansion platform leveraging the properties of nicotinamide, or NAM, to allogeneic cell sources including umbilical cord blood-derived cells and natural killer, or NK, cells to create cell therapy candidates with the potential to redefine standards of care. Its primary product candidate is Omidubicel, an advanced cell therapy candidate for allogeneic hematopoietic stem cell transplant and GDA-201 is the company's lead investigational NK cell-based cancer immunotherapy product candidate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GMDAQ has been successfully added to your 